{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:39:33Z","timestamp":1769200773697,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00277-020-04306-w","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T17:03:51Z","timestamp":1603299831000},"page":"105-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis"],"prefix":"10.1007","volume":"100","author":[{"given":"Benedetta","family":"Rambaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Diral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Donsante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Mottadelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Dander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Isimbaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Pioltelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Maria","family":"Elli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Pievani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-6476","authenticated-orcid":false,"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"4306_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"4306_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","volume":"129","author":"W Vainchenker","year":"2017","unstructured":"Vainchenker W, Kralovics R (2017) Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 129:667\u2013679. https:\/\/doi.org\/10.1182\/blood-2016-10-695940","journal-title":"Blood"},{"key":"4306_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ajh.24592","volume":"91","author":"A Tefferi","year":"2016","unstructured":"Tefferi A (2016) Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 91:1262\u20131271. https:\/\/doi.org\/10.1002\/ajh.24592","journal-title":"Am J Hematol"},{"key":"4306_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11914-011-0075-y","volume":"9","author":"J Isern","year":"2011","unstructured":"Isern J, Mendez-Ferrer S (2011) Stem cell interactions in a bone marrow niche. Curr Osteoporos Rep 9:210\u2013218. https:\/\/doi.org\/10.1007\/s11914-011-0075-y","journal-title":"Curr Osteoporos Rep"},{"key":"4306_CR5","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1186\/1755-1536-5-S1-S20","volume":"5","author":"M-C Le Bousse-Kerdiles","year":"2012","unstructured":"Le Bousse-Kerdiles M-C (2012) Primary myelofibrosis and the \u201cbad seeds in bad soil\u201d concept. Fibrogenesis Tissue Repair 5:S20. https:\/\/doi.org\/10.1186\/1755-1536-5-S1-S20","journal-title":"Fibrogenesis Tissue Repair"},{"key":"4306_CR6","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1182\/blood-2008-06-158386","volume":"112","author":"J-J Lataillade","year":"2008","unstructured":"Lataillade J-J, Pierre-Louis O, Hasselbalch HC, Uzan G, Jasmin C, Martyr\u00e9 MC, le Bousse-Kerdil\u00e8s MC, French INSERM and the European EUMNET Networks on Myelofibrosis (2008) Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood 112:3026\u20133035. https:\/\/doi.org\/10.1182\/blood-2008-06-158386","journal-title":"Blood"},{"key":"4306_CR7","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1182\/blood-2018-02-834820","volume":"131","author":"R Kramann","year":"2018","unstructured":"Kramann R, Schneider RK (2018) The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis. Blood 131:2111\u20132119. https:\/\/doi.org\/10.1182\/blood-2018-02-834820","journal-title":"Blood"},{"key":"4306_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.leukres.2007.07.001","volume":"32","author":"L Pieri","year":"2008","unstructured":"Pieri L, Guglielmelli P, Bogani C, Bosi A, Vannucchi AM, Myeloproliferative Disorders Research Consortium (MPD-RC) (2008) Mesenchymal stem cells from JAK2(V617F) mutant patients with primary myelofibrosis do not harbor JAK2 mutant allele. Leuk. Res. 32:516\u2013517","journal-title":"Leuk. Res."},{"key":"4306_CR9","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/leu.2014.97","volume":"28","author":"MA Avanzini","year":"2014","unstructured":"Avanzini MA, Bernardo ME, Novara F et al (2014) Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms. Leukemia 28:1742\u20131745","journal-title":"Leukemia"},{"key":"4306_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/bjh.13471","volume":"172","author":"V Abbonante","year":"2016","unstructured":"Abbonante V, Gruppi C, Catarsi P, Avanzini MA, Tira ME, Barosi G, Rosti V, Balduini A (2016) Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells. Br J Haematol 172:140\u2013144. https:\/\/doi.org\/10.1111\/bjh.13471","journal-title":"Br J Haematol"},{"key":"4306_CR11","doi-asserted-by":"publisher","unstructured":"Martinaud C, Desterke C, Konopacki J et al (2015) Osteogenic potential of mesenchymal stromal cells contributes to primary myelofibrosis. Cancer Res 75:4753 LP \u2013 4765. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3696","DOI":"10.1158\/0008-5472.CAN-14-3696"},{"key":"4306_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-014-0092-2","volume":"7","author":"RK Schneider","year":"2014","unstructured":"Schneider RK, Ziegler S, Leisten I, Ferreira MSV, Schumacher A, Rath B, Fahrenkamp D, M\u00fcller-Newen G, Crysandt M, Wilop S, Jost E, Koschmieder S, Kn\u00fcchel R, Br\u00fcmmendorf TH, Ziegler P (2014) Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms. J Hematol Oncol 7:92. https:\/\/doi.org\/10.1186\/s13045-014-0092-2","journal-title":"J Hematol Oncol"},{"key":"4306_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","volume":"20","author":"RK Schneider","year":"2017","unstructured":"Schneider RK, Mullally A, Dugourd A et al (2017) Gli1+ mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target. Cell Stem Cell 20:785\u2013800. e8. https:\/\/doi.org\/10.1016\/j.stem.2017.03.008","journal-title":"Cell Stem Cell"},{"key":"4306_CR14","doi-asserted-by":"publisher","unstructured":"Namwanje M, Brown CW (2016) Activins and inhibins: roles in development, physiology, and disease. Cold Spring Harb Perspect Biol 8. https:\/\/doi.org\/10.1101\/cshperspect.a021881","DOI":"10.1101\/cshperspect.a021881"},{"key":"4306_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.hoc.2013.12.001","volume":"28","author":"L Breda","year":"2014","unstructured":"Breda L, Rivella S (2014) Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production. Hematol Oncol Clin North Am 28:375\u2013386. https:\/\/doi.org\/10.1016\/j.hoc.2013.12.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"4306_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1182\/blood-2018-11-876888","volume":"133","author":"P Fenaux","year":"2019","unstructured":"Fenaux P, Kiladjian JJ, Platzbecker U (2019) Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis. Blood 133:790\u2013794. https:\/\/doi.org\/10.1182\/blood-2018-11-876888","journal-title":"Blood"},{"key":"4306_CR17","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, et al (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90:1128 LP \u2013 1132"},{"key":"4306_CR18","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2003-12-4452","volume":"104","author":"Y Sakaguchi","year":"2004","unstructured":"Sakaguchi Y, Sekiya I, Yagishita K, Ichinose S, Shinomiya K, Muneta T (2004) Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 104:2728\u20132735. https:\/\/doi.org\/10.1182\/blood-2003-12-4452","journal-title":"Blood"},{"key":"4306_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (London, England) 365:1054\u20131061. https:\/\/doi.org\/10.1016\/S0140-6736(05)71142-9","journal-title":"Lancet (London, England)"},{"key":"4306_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2141.2010.08083.x","volume":"149","author":"EM Boyd","year":"2010","unstructured":"Boyd EM, Bench AJ, Goday-Fernandez A et al (2010) Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis. Br J Haematol 149:250\u2013257. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08083.x","journal-title":"Br J Haematol"},{"key":"4306_CR21","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, Avezov E, Li J, Kollmann K, Kent DG, Aziz A, Godfrey AL, Hinton J, Martincorena I, van Loo P, Jones AV, Guglielmelli P, Tarpey P, Harding HP, Fitzpatrick JD, Goudie CT, Ortmann CA, Loughran SJ, Raine K, Jones DR, Butler AP, Teague JW, O'Meara S, McLaren S, Bianchi M, Silber Y, Dimitropoulou D, Bloxham D, Mudie L, Maddison M, Robinson B, Keohane C, Maclean C, Hill K, Orchard K, Tauro S, du MQ, Greaves M, Bowen D, Huntly BJP, Harrison CN, Cross NCP, Ron D, Vannucchi AM, Papaemmanuil E, Campbell PJ, Green AR (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391\u20132405. https:\/\/doi.org\/10.1056\/NEJMoa1312542","journal-title":"N Engl J Med"},{"key":"4306_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"115","author":"F Passamonti","year":"2010","unstructured":"Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A, Guglielmelli P, Pungolino E, Caramella M, Maffioli M, Pascutto C, Lazzarino M, Cazzola M, Tefferi A (2010) A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 115:1703\u20131708. https:\/\/doi.org\/10.1182\/blood-2009-09-245837","journal-title":"Blood"},{"key":"4306_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"The International Society for Cellular Therapy position statement. Cytotherapy"},{"key":"4306_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","volume":"131","author":"B Sacchetti","year":"2007","unstructured":"Sacchetti B, Funari A, Michienzi S, di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324\u2013336. https:\/\/doi.org\/10.1016\/j.cell.2007.08.025","journal-title":"Cell"},{"key":"4306_CR25","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","volume":"17","author":"G Barosi","year":"1999","unstructured":"Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954\u20132970. https:\/\/doi.org\/10.1200\/JCO.1999.17.9.2954","journal-title":"J Clin Oncol"},{"key":"4306_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","volume":"342","author":"A Tefferi","year":"2000","unstructured":"Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255\u20131265. https:\/\/doi.org\/10.1056\/NEJM200004273421706","journal-title":"N Engl J Med"},{"key":"4306_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1242\/dev.142836","volume":"144","author":"A Pievani","year":"2017","unstructured":"Pievani A, Sacchetti B, Corsi A, Rambaldi B, Donsante S, Scagliotti V, Vergani P, Remoli C, Biondi A, Robey PG, Riminucci M, Serafini M (2017) Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone\/marrow organoid in vivo. Dev 144:1035\u20131044. https:\/\/doi.org\/10.1242\/dev.142836","journal-title":"Dev"},{"key":"4306_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3324\/haematol.2018.188664","volume":"104","author":"F Portale","year":"2019","unstructured":"Portale F, Cricri G, Bresolin S et al (2019) ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells. Haematologica 104:533\u2013545. https:\/\/doi.org\/10.3324\/haematol.2018.188664","journal-title":"Haematologica"},{"key":"4306_CR29","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S, Santo L, Cirstea D, Patel K, Sohani AR, Guimaraes A, Xie W, Chauhan D, Schoonmaker JA, Attar E, Churchill M, Weller E, Munshi N, Seehra JS, Weissleder R, Anderson KC, Scadden DT, Raje N (2010) Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc Natl Acad Sci U S A 107:5124\u20135129. https:\/\/doi.org\/10.1073\/pnas.0911929107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4306_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3324\/haematol.13598","volume":"94","author":"C Tripodo","year":"2009","unstructured":"Tripodo C, Di Bernardo A, Ternullo MP et al (2009) CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis. Haematologica 94:127\u2013130. https:\/\/doi.org\/10.3324\/haematol.13598","journal-title":"Haematologica"},{"key":"4306_CR31","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1182\/blood-2010-08-304287","volume":"117","author":"A Tormin","year":"2011","unstructured":"Tormin A, Li O, Brune JC, Walsh S, Sch\u00fctz B, Ehinger M, Ditzel N, Kassem M, Scheding S (2011) CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117:5067\u20135077. https:\/\/doi.org\/10.1182\/blood-2010-08-304287","journal-title":"Blood"},{"key":"4306_CR32","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/s41375-019-0379-y","volume":"33","author":"DAC Fisher","year":"2019","unstructured":"Fisher DAC, Miner CA, Engle EK, Hu H, Collins TB, Zhou A, Allen MJ, Malkova ON, Oh ST (2019) Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFkappaB signaling. Leukemia 33:1978\u20131995. https:\/\/doi.org\/10.1038\/s41375-019-0379-y","journal-title":"Leukemia"},{"key":"4306_CR33","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.1182\/blood-2009-07-234880","volume":"114","author":"N Kroger","year":"2009","unstructured":"Kroger N, Holler E, Kobbe G et al (2009) Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 114:5264\u20135270. https:\/\/doi.org\/10.1182\/blood-2009-07-234880","journal-title":"Blood"},{"key":"4306_CR34","doi-asserted-by":"publisher","first-page":"e0182470","DOI":"10.1371\/journal.pone.0182470","volume":"12","author":"TL Ramos","year":"2017","unstructured":"Ramos TL, Sanchez-Abarca LI, Roson-Burgo B et al (2017) Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis. PLoS One 12:e0182470. https:\/\/doi.org\/10.1371\/journal.pone.0182470","journal-title":"PLoS One"},{"key":"4306_CR35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977\u2013988. https:\/\/doi.org\/10.1016\/j.immuni.2006.10.016","journal-title":"Immunity"},{"key":"4306_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.exphem.2007.10.001","volume":"36","author":"AR Migliaccio","year":"2008","unstructured":"Migliaccio AR, Martelli F, Verrucci M, Migliaccio G, Vannucchi AM, Ni H, Xu M, Jiang Y, Nakamoto B, Papayannopoulou T, Hoffman R (2008) Altered SDF-1\/CXCR4 axis in patients with primary myelofibrosis and in the Gata1low mouse model of the disease. Exp Hematol 36:158\u2013171. https:\/\/doi.org\/10.1016\/j.exphem.2007.10.001","journal-title":"Exp Hematol"},{"key":"4306_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bcmd.2007.01.003","volume":"38","author":"V Rosti","year":"2007","unstructured":"Rosti V, Massa M, Vannucchi AM, Bergamaschi G, Campanelli R, Pecci A, Viarengo G, Meli V, Marchetti M, Guglielmelli P, Bruno E, Xu M, Hoffman R, Barosi G (2007) The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia. Blood Cells, Mol Dis 38:280\u2013286. https:\/\/doi.org\/10.1016\/j.bcmd.2007.01.003","journal-title":"Blood Cells, Mol Dis"},{"key":"4306_CR38","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1634\/stemcells.2008-0377","volume":"26","author":"C Bogani","year":"2008","unstructured":"Bogani C, Ponziani V, Guglielmelli P, Desterke C, Rosti V, Bosi A, le Bousse-Kerdil\u00e8s MC, Barosi G, Vannucchi AM, for the Myeloproliferative Disorders Research Consortium (2008) Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis. Stem Cells 26:1920\u20131930. https:\/\/doi.org\/10.1634\/stemcells.2008-0377","journal-title":"Stem Cells"},{"key":"4306_CR39","doi-asserted-by":"publisher","unstructured":"Wang X, Cho SY, Hu CS, et al (2015) C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients. Exp Hematol 43:100\u20139.e1. https:\/\/doi.org\/10.1016\/j.exphem.2014.10.013","DOI":"10.1016\/j.exphem.2014.10.013"},{"key":"4306_CR40","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1182\/blood-2011-03-342691","volume":"117","author":"S Sozzani","year":"2011","unstructured":"Sozzani S, Musso T (2011) The yin and yang of Activin A. Blood 117:5013\u20135015. https:\/\/doi.org\/10.1182\/blood-2011-03-342691","journal-title":"Blood"},{"key":"4306_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bcmd.2014.12.005","volume":"54","author":"F Ciaffoni","year":"2015","unstructured":"Ciaffoni F, Cassella E, Varricchio L, Massa M, Barosi G, Migliaccio AR (2015) Activation of non-canonical TGF-\u03b21 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis. Blood Cells, Mol Dis 54:234\u2013241. https:\/\/doi.org\/10.1016\/j.bcmd.2014.12.005","journal-title":"Blood Cells, Mol Dis"},{"key":"4306_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/cancers7010070","volume":"7","author":"H Loomans","year":"2014","unstructured":"Loomans H, Andl C (2014) Intertwining of Activin A and TGF\u03b2 signaling: dual roles in cancer progression and cancer cell invasion. Cancers (Basel) 7:70\u201391. https:\/\/doi.org\/10.3390\/cancers7010070","journal-title":"Cancers (Basel)"},{"key":"4306_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1006\/bbrc.1997.8020","volume":"242","author":"M Shiozaki","year":"1998","unstructured":"Shiozaki M, Kosaka M, Eto Y (1998) Activin A: a commitment factor in erythroid differentiation. Biochem Biophys Res Commun 242:631\u2013635. https:\/\/doi.org\/10.1006\/bbrc.1997.8020","journal-title":"Biochem Biophys Res Commun"},{"key":"4306_CR44","first-page":"1090","volume":"19","author":"K Nakao","year":"1991","unstructured":"Nakao K, Kosaka M, Saito S (1991) Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors. Exp Hematol 19:1090","journal-title":"Exp Hematol"},{"key":"4306_CR45","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00277-019-03695-x","volume":"98","author":"E Voskaridou","year":"2019","unstructured":"Voskaridou E, Ntanasis-Stathopoulos I, Christoulas D, Dimopoulou M, Komninaka V, Repa K, Papatheodorou A, Terpos E (2019) Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell\/beta-thalassemia and correlates with markers of hemolysis and bone mineral density. Ann Hematol 98:1583\u20131592. https:\/\/doi.org\/10.1007\/s00277-019-03695-x","journal-title":"Ann Hematol"},{"key":"4306_CR46","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","volume":"382","author":"MD Cappellini","year":"2020","unstructured":"Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A, BELIEVE Investigators (2020) A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia. N Engl J Med 382:1219\u20131231. https:\/\/doi.org\/10.1056\/NEJMoa1910182","journal-title":"N Engl J Med"},{"key":"4306_CR47","doi-asserted-by":"publisher","unstructured":"Iancu-Rubin C, Mosoyan G, Wang J, et al (2013) Stromal cell-mediated inhibition of erythropoiesis can be attenuated by sotatercept (ACE-011), an activin receptor type II ligand trap. Exp Hematol 41:155-166.e17. https:\/\/doi.org\/10.1016\/j.exphem.2012.12.002","DOI":"10.1016\/j.exphem.2012.12.002"},{"key":"4306_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1182\/blood.V130.Suppl_1.255.255","volume":"130","author":"P Bose","year":"2017","unstructured":"Bose P, Daver N, Pemmaraju N et al (2017) Sotatercept (ACE-011) alone and in combination with ruxolitinib in patients (pts) with myeloproliferative neoplasm (MPN)-associated myelofibrosis (MF) and anemia. Blood 130:255. https:\/\/doi.org\/10.1182\/blood.V130.Suppl_1.255.255","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04306-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:24:38Z","timestamp":1634772278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04306-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4306"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04306-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"25 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of San Gerardo Hospital-Monza (date: 31 October 2014; protocol code: BM-NICHE).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}